Go Pro

Scribe Therapeutics (SCTX) Earnings Date, Estimates & Call Transcripts

Scribe Therapeutics logo
$20.62 -0.99 (-4.58%)
As of 01:27 PM Eastern

Scribe Therapeutics Earnings Summary

Scribe Therapeutics announced Q2 2026 earnings on September 2, 2026, reporting an EPS of -$3.84, which topped analysts' consensus estimates of -$6.20 by $2.36. Quarterly revenue was reported to be $1.92 million, below analyst estimates of $3.10 million. With a trailing EPS of $0.00, Scribe Therapeutics' earnings are expected to grow next year, from ($3.68) to ($2.52) per share.

Consensus EPS
(Sep. 2)
-$6.20
Actual EPS
(Sep. 2)
-$3.84 Beat By $2.36
Actual Revenue
(Sep. 2)
$1.92M

Q2 2026 Earnings Resources

Get Scribe Therapeutics Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Scribe Therapeutics and other key companies, straight to your inbox.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Scribe Therapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q2 20261-$6.20-$6.20-$6.20
Q3 20261-$0.42-$0.42-$0.42
Q4 20261-$0.40-$0.40-$0.40
2026 3 -$7.02 -$7.02 -$7.02
Q1 20271-$0.47-$0.47-$0.47
Q2 20271-$0.55-$0.55-$0.55
Q3 20271-$0.68-$0.68-$0.68
Q4 20271-$0.82-$0.82-$0.82

Scribe Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
9/2/2026Q2 2026-$6.20-$3.84+$2.36-$2.62$3.10M$1.92M

Scribe Therapeutics Earnings - Frequently Asked Questions

Scribe Therapeutics (NASDAQ:SCTX) last announced its quarterly earning data on Wednesday, September 2, 2026. Learn more on SCTX's earnings history.

In the previous quarter, Scribe Therapeutics (NASDAQ:SCTX) reported ($3.84) earnings per share (EPS) to beat the analysts' consensus estimate of ($6.20) by $2.36. Learn more on analysts' earnings estimate vs. SCTX's actual earnings.

Scribe Therapeutics' earnings are expected to grow from ($3.68) per share to ($2.52) per share in the next year.


Earnings data for NASDAQ:SCTX is sourced from Fiscal.ai, with the most recent quarter reported on 9/2/2026. New results are added as companies report their earnings.
From Our Partners